1 |
|
Hepatic ABC Transporters
|
88 |
1.430 |
|
2 |
|
Hepatitis C and hepatocellular carcinoma
|
55 |
1.430 |
SuperPathway |
- Hepatitis C and hepatocellular carcinoma
|
Pathways |
- Hepatitis C and hepatocellular carcinoma
|
|
3 |
|
NF-kappaB Signaling
|
327 |
0.778 |
Genes names |
- Hepatitis A Virus Cellular Receptor 1
- Hepatitis A Virus Cellular Receptor 2
|
|
4 |
|
Ebola virus infection in host
|
129 |
0.778 |
Genes names |
- Hepatitis A Virus Cellular Receptor 1
- Hepatitis A Virus Cellular Receptor 2
|
|
5 |
|
Toll-like receptor signaling pathway
|
285 |
0.701 |
|
6 |
|
Transport of inorganic cations/anions and amino acids/oligopeptides
|
728 |
0.550 |
|
7 |
|
Statin inhibition of cholesterol production
|
31 |
0.550 |
|
8 |
|
Fatty acid beta-oxidation
|
34 |
0.550 |
|
9 |
|
Early SARS-CoV-2 Infection Events
|
83 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 1
|
|
10 |
|
Familial hyperlipidemia type 1
|
30 |
0.550 |
|
11 |
|
Cytokine Signaling in Immune system
|
732 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 2
|
|
12 |
|
Plasma lipoprotein assembly, remodeling, and clearance
|
75 |
0.550 |
|
13 |
|
Cholesterol metabolism
|
72 |
0.550 |
|
14 |
|
Interleukin-2 family signaling
|
72 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 2
|
|
15 |
|
T cell modulation in pancreatic cancer
|
45 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 2
|
|
16 |
|
SARS-CoV-2 innate immunity evasion and cell-specific immune response
|
50 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 2
|
|
17 |
|
SARS-CoV-2 Infection
|
414 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 1
|
|
18 |
|
Infectious disease
|
1747 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 1
|
|
19 |
|
Innate Immune System
|
2025 |
0.550 |
Genes names |
- Hepatitis A Virus Cellular Receptor 2
|
|
20 |
|
Triacylglyceride synthesis
|
38 |
0.550 |
|